By Arti Loftus
The future of orthopedic oncology is always expanding and deepening, with advances in personalized medicine, imaging technologies, and emerging therapies designed to improve patient outcomes. As research continues to uncover the complexities of tumor biology, we can expect to see the development of more effective and targeted treatments for patients with musculoskeletal tumors.
Number Analytics, earlier this year, published “The Future of Orthopedic Oncology: Emerging Trends; A Comprehensive Guide to the Latest Therapies and Technologies in Bone Cancer Treatment,” highlighting the most recent advancements in the field.
Personalized Medicine and its applications in Orthopedic Oncology are explored in the report and defined as “tailoring medical treatment to an individual’s unique genetic, environmental, and lifestyle factors” with great potential to revolutionize treatment approaches by providing targeted therapies with fewer side effects and improved outcomes.
The application of personalized medicine in orthopedic oncology involves several key steps, the authors write:
- Genetic profiling: Analyzing the genetic characteristics of a patient’s tumor to identify potential targets for therapy.
- Biomarker testing: Using biomarkers to predict treatment response and monitor disease progression.
- Targeted therapy: Using therapies that are designed to target specific molecular mechanisms involved in tumor growth and progression.
While there are many benefits, there are also challenges associated with personalized medicine, according to the report, including high costs, limited availability, and complexity.
Specific examples of personalized medicine in practice are reviewed, including targeted therapy for osteosarcoma and genetic profiling for Ewing’s sarcoma.
In a future article, we’ll share the report’s high-level findings in the field of advanced imaging technologies.
